🇺🇸 FDA
Pipeline program

Ferinject 50 mg/ml dispersión inyectable y para perfusión

IRONPAD

Approved small_molecule active

Quick answer

Ferinject 50 mg/ml dispersión inyectable y para perfusión for Anemia in patients with chronic ischemia of the lower limb ischemia is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Anemia in patients with chronic ischemia of the lower limb ischemia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials